Collagen Type IV Variants and Kidney Cysts: Decoding the COL4A Puzzle
- PMID: 40565535
- PMCID: PMC12193310
- DOI: 10.3390/genes16060642
Collagen Type IV Variants and Kidney Cysts: Decoding the COL4A Puzzle
Abstract
Pathogenic variants in type IV collagen genes (COL4A3, COL4A4, COL4A5) are classically associated with Alport syndrome (AS), a hereditary nephropathy primarily affecting the glomerular basement membrane (GBM). Recent findings, however, suggest a broader phenotypic spectrum that includes renal cyst formation, raising questions about overlapping mechanisms with other cystic kidney diseases. Clinically, renal cysts have been increasingly reported in patients with autosomal dominant and X-linked forms of Alport syndrome, particularly in association with glycine missense variants. The most recent studies focusing on the cystic phenotype in Alport syndrome provide growing support for the idea that variants in type IV collagen genes are associated with an increased likelihood of developing renal cysts, likely through mechanisms involving the structural integrity of renal basement membranes. In this review, we explore evidence from murine models and human studies indicating defects in collagen IV and discuss their contribution to cystogenesis. These observations underscore the need for broader genetic screening strategies and further investigation into the molecular mechanisms underlying this emerging phenotype.
Keywords: ADPKD; Alport syndrome; COL4A; collagen variants; cystic kidney disease; kidney cysts.
Conflict of interest statement
In the past 3 years, C.R. has been on advisory boards or speakers’ bureaus for AstraZeneca, Afer-etica, Asahi, Bayer, B. Braun, Baxter, BioMérieux, CytoSorbents, Estor, GE, Jafron, Medica, Med-tronic, Nipro, and Toray. All the other authors declare no conflicts of interest.
References
-
- Devuyst O., Ahn C., Barten T.R., Brosnahan G., Cadnapaphornchai M.A., Chapman A.B., Cornec-Le Gall E., Drenth J.P., Gansevoort R.T., Harris P.C., et al. KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) Kidney Int. 2025;107:S1–S239. doi: 10.1016/j.kint.2024.07.009. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials